Rising Pharma Holdings Inc.
Coverage of Rising Pharma Holdings Inc. in the Nexus archive.
- Retiran popular medicamento para la alergia por riesgos potencialmente mortales
Un popular medicamento para alergias, clorhidrato de cetirizina, fue retirado en Estados Unidos debido a contaminación cruzada con ranitidina, lo que podría causar reacciones alérgicas graves o mortales. La FDA advirtió sobre el riesgo, y Unique Pharmaceutical Laboratories realizó el retiro voluntario de cuatro lotes distribuidos por Rising Pharma Holdings Inc.
- Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
An over-the-counter allergy medication, cetirizine hydrochloride, sold nationwide by Unique Pharmaceutical Laboratories is being recalled due to contamination with ranitidine (Zantac). The FDA confirmed the recall, which was triggered by a pharmacy technician noticing incorrect pill colors. The mix-up could cause life-threatening reactions in individuals hypersensitive to ranitidine.
- Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets, a generic allergy medication, due to contamination with ranitidine (Zantac). The recall was prompted by a pharmacy technician noticing incorrect pills, but no illnesses have been reported.